Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Accelerate Diagnostics, Inc. develops rapid in vitro diagnostic systems for identifying infectious pathogens and determining antibiotic susceptibility, primarily targeting hospital microbiology laboratories. Its core products include the Accelerate Pheno system and test kits, which deliver faster pathogen ID and antimicrobial susceptibility testing than traditional methods. The company’s technology aims to improve patient outcomes and reduce healthcare costs by enabling timely, targeted antibiotic therapy to combat antibiotic resistance and sepsis.
This description was generated via AI from an annual report. Updated about 1 year ago.